Regulations.gov document
Notice of Final Rule re Current Good Manufacturing Practice for Blood and Blood…
Notice · FDA-1999-N-0114 · posted Aug 27, 2007
Key facts
| Document ID | FDA-1999-N-0114-0001 |
|---|---|
| Title | Notice of Final Rule re Current Good Manufacturing Practice for Blood and Blood Components; Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting Hepatitis C Virus Infection ("Lookback") |
| Document type | Notice |
| Subtype | Notice of Final Rule |
| Agency | FDA |
| Docket | FDA-1999-N-0114 |
| Posted | Aug 27, 2007 |
| Federal Register citation | 66FR31146 - 31159 |
| FR document number | 66FR31146 - 31159 |
| CFR | 21 CFR Parts 606 and 610 |
| Comment period opens | Aug 24, 2007 |
| Effective date | Aug 24, 2007 |
At a glance
- 10–99 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: